Abstract. The processes and mechanisms underlying brain injuries due to ischemia and anoxia have yet to be determined.
Introduction
The processes and mechanisms underlying brain injuries due to ischemia and anoxia remain to be elucidated. Additionally, few clinical treatments are currently available for these types of injury. Activins, which are widely distributed in the body, possess biological activity and are capable of regulating the restoration, differentiation and survival of injured cells. These molecules also promote tissue regeneration, participate in the processes of various diseases and exhibit marked tissue and organ specificity (1) . Investigations into neuronal disorders have led to an increased interest in activin A (ActA), which acts as a recognized strong protectin in the nervous system (2) . ActA is a member of the transforming growth factor (TGF) β1 super-family (4) (5) (6) , and transmits signals by binding to serine-threonine receptors on cell membranes (7) . The activation of different ligands of ActA receptors may lead to different physiological and pathological effects in vivo. ActA has been shown to exert its effects through stimulation of the Smad signal transduction pathway (3), including Smad2 and Smad3. Receptor-regulated Smad proteins then form a multimer with Smad4, which translocates into the nucleus and co-regulates target gene transcription and other biological functions with intranuclear cofactors (8) (9) (10) .
It is clear that exogenous activin plays a protective role in the nervous system. However, few studies have focused on the protective effect of ActA on neurons. Therefore, the aim of the present study was to elucidate the protective mechanism of action of ActA in an in vitro oxygen/glucose deprivation (OGD) model system. To this end, PC12 cells were differentiated into neuron-like cells and were then exposed to different concentrations of exogenous ActA. The effect of this treatment was assessed under anoxic and ischemic conditions on PC12 survival and caspase-3 expression, a key apoptotic regulatory protein.
Materials and methods

PC12 cell culture. PC12 cells (Beijing Chinese Redbud
Biological Co. Ltd., Beijing, China) were plated into polylysine-coated flasks containing Dulbecco's modified Eagle's medium (DMEM; Gibco, Carlsbad, CA, USA). The cells were then incubated in a 5% CO 2 incubator at 37˚C, and their media were changed after two days. When the cells reached 85% confluence, they were used for the experiments.
PC12 cell differentiation. Glass coverslips were scratched and placed into 24-well plates. PC12 cells were inoculated into these wells at a concentration of 5x10 4 cells/ml and cultivated for 24 h. Nerve growth factor (NGF) diluted in DMEM (0.05 mg/ml) was then added to the culture well. The morphological changes following NGF treatment were observed after 0, 24, 36 and 72 h using an inverted microscope (Olympus, Tokyo, Japan). Neurites that were >2-fold the length of the cell bodies were used to classify the cells as neuron-like, as were multiple neuritis. The rate of differentiation into neuron-like cells was calculated by observation. Images were obtained from five wells to give the mean value.
Immunocytochemistry. Following treatment, cells adhering to the glass coverslips were removed from the 24-well plates and washed in 0.01 M phosphate-buffered saline (PBS). The cells were then fixed in 4% paraformaldehyde, and exposed (10 min) to 0.1% Triton X-100/PBS (PBST) to permeabilize the cells. Goat serum (10% in PBS) was subsequently added for 30 min following the removal of the PBST to block non-specific binding sites in the cells. One drop of rabbit anti-rat microtubule-associated protein 2 antibody (1 mg/ml, Beijing Bo'ao Biological Co., Ltd., Beijing, China) was then added to the coverslips, which were incubated overnight in a humidified container at 4˚C. The following morning, the coverslips were washed and a drop of FITC-labeled goat antirabbit IgG (2 mg/ml; Beijing Bo'ao Biotechnology Co., Ltd., Beijing, China) was added to the cells and incubated at 37˚C for 20 min. The coverslips were sealed with anti-quenching mounting medium (Beijing Bo'ao Biotechnology Co., Ltd.). A negative control was created by using PBS instead of the primary antibody. The cells were observed under a fluorescence microscope (Olympus).
Establishment of the oxygen/glucose deprivation (OGD)
model. The model was established using an improved method, as described by Guo et al (24) . Briefly, cell culture flasks were placed in sealable glassware. Sterile water (100 ml) was injected into the glassware and sodium sulfoxylate (40 g) was also placed in the glassware for oxygen removal. The glassware was then sealed with a rubber tube to keep the atmosphere in the bottle at CO 2 5%, N 2 95%. Glucose-free fetal bovine serum (10%) DMEM was added to the cell culture bottles, as well as sodium sulfoxylate (final concentration 1 mM), in order to continue culturing of PC12 cells. The hypoxia chamber was then placed in an incubator and maintained at 37˚C.
Exogenous ActA and detection of the cell survival rate using the MTT assay. Cells were cultured for 3, 6, 9, 12 and 16 h in hypoxic conditions, and suspended (100 µl) in wells of culture plates at a density of 5x10 4 cells/ml. Cells were then incubated in 5% CO 2 at 37˚C, and recombinant human ActA (rhActA) was added at concentrations of 10, 20, 30, 50 or 100 µmol/ml. When the cells reached confluence, the MTT solution (5 mg/ml; 20 µl) was added to each well and cultured for a further 4 h. The MTT solution was then removed and dimethyl sulfoxide (150 µl) was added to each well. After the plates were agitated on a table concentrator for 10 min, the optical density at 490 nm was measured to determine the cell survival rate (%), calculated as: (light absorbance at 490 nm x 100% in the experimental group)/(light absorbance at 490 nm x 100% in the control group). Experiments were repeated three times.
Hoechst 33342 staining assay. Following cell culture for 3, 6, 9, 12, 16 and 24 h, scratched coverslips were placed into 12-well plates. Cells (5x10 4 /ml) were then added to each well and were subjected to OGD, as described above. The cells were fixedy by removing the culture medium and replacing it with 0.5 ml 95% ethanol. After being washed twice with PBS, 0.5 ml of Hoechst 33342 staining solution was added to the cells. The coverslips were mounted in a fluorescence anti-quenching mounting medium, and the cells were observed under a fluorescence microscope. Hoechst 33342 staining revealed that the nuclei of apoptotic cells appeared bright blue and condensed. The cells were quantified as percentage cells undergoing apoptosis, calculated as: apoptotic cell number/total cell number under the x100 field of vision x 100. Counts were repeated three times to establish a mean value.
Western blot analysis of ActAIIR, Smad3, Smad4 and caspase-3 in PC12 cells. Culture medium was replaced with 1X sodium dodecyl sulfate (SDS) sample buffer after PC12 cells under OGD were exposed to rhActA. The cells were scraped from the plates and transferred to centrifuge tubes, where they were sonicated and boiled for 5 min. Samples were centrifuged at 12,000 rpm for 5 min and the supernatant was removed. The pellets were resuspended, separated using electrophoresis, and transferred to a membrane. The membrane was then placed in a blocking solution (5% skim milk powder) and probed with rabbit anti-rat primary antibodies (1:200) against ActAIIR, Smad3, Smad4, pro-caspase-3, active caspase-3 and mouse anti-rat β-actin monoclonal antibody (200 µg/ml, Santa Cruz Biotechnology, Inc., Santa Cruz, CA, USA). The membrane was incubated overnight at 4˚C and washed three times the following morning (5 min each). Following this washing step, the membranes were incubated with horseradish peroxidase (HRP)-conjugated goat anti-rabbit secondary antibody (1:1,000, Santa Cruz Biotechnology) and incubated subsequent to agitation for 2 h at 37˚C. The membranes were then washed three times in 0.1% Tween-20/Tris-buffered saline (TTBS) cleaning solution, (5 min), and then in TBS alone for 5 min. Band absorbance was measured with a gelatin image analysis system (Olympus) and the absorbance ratio was calculated against the absorbance for the β-actin band. Experiments were repeated three times.
Statistical analysis.
Results are shown as the mean ± SD. Statistical analysis was conducted using SPSS 13.0 software (SPSS; Chicago, IL, USA). The difference between groups was analyzed using a one-way analysis of variance, and multiple comparisons were conducted using the SNK-q method. P<0.05 indicated a statistically significant difference.
Results
Morphological analysis of differentiated PC12 cells
PC12 cell morphology. Microscopy revealed that after 12 h in culture, PC12 cells had still not adhered to the culture flask. After 36 h, the cells had adhered and began to rapidly divide, until confluence was reached after 72 h (Fig. 1) .
Nerve growth factor-induced differentiation of PC12 cells into neuron-like cells. NGF induced PC12 cells to differentiate into neuron-like cells after 24 h. Synapses formed between PC12 cells, and after 36 h axons appeared to grow longer and thicker. After 72 h, the length of the axons was >5-fold the length of the cell bodies. These axons were interlaced into a network and demonstrated neuronal characteristics. These neuronal-like cells accounted for >95% of the culture (Fig. 2) .
After 72 h post-NGF induction of PC12 cells, immunof luorescence staining showed that cells expressed microtubule-associated protein 2 (MAP2) (Fig. 3) .
Rate of cell survival after PC12 cells were subjected to OGD. An MTT assay revealed that after 3 h of OGD, the survival rate of PC12 cells was reduced and continued to decrease with the length of OGD (P<0.05; Fig. 4 ).
After PC12 cells were subjected to 3 and 6 h of OGD, apoptotic cells were observed, as detected by condensed nuclei visualized by Hoechst 33342 staining. After 9 h, apoptotic cells increased in number. After 12 h of OGD, the majority of cells appeared bright, pyknotic, heavily stained and exhibited apoptotic blebs. The majority of the cells died after 24 h of OGD and very few normal cells were evident (Figs. 5 and 6 ).
The effect of exogenous ActA on injured PC12 cells after OGD
rhActA increased the survival rate of PC12 cells after OGD. As shown above, the cell survival rate of PC12 cells under OGD was markedly lower than that of the control group. However, this cell death was decreased after 24 h of rhActA stimulation. The cell survival rate after 6 h was increased in the rhActA + OGD group compared with the OGD group. Furthermore, the survival rate was positively correlated with the final concentration of rhActA. The cell survival rate in the rhActA (100 ng/ml) group was slightly higher than that of the 50 ng/ml group, however, this difference was not significant. A comparison of the cell survival rate in each group is shown in Fig. 7 . rhActA prevented apoptosis after OGD in PC12 cells. Although most of the nuclei in the control group were not condensed or showed signs of apoptosis, a small number of apoptotic cells were observed (Fig. 8) . Apoptosis was evident Hoechst 33342 staining for apoptosis in PC12 cells under oxygen/glucose deprivation (OGD) stimulated by rhActA (100 ng/ml) compared with the control group under OGD alone. The nuclei in the control group were elliptical and the chromatin was evenly stained. The apoptotic cell number in the OGD 6 h group markedly increased and endonuclear chromatin was evenly distributed, showing characteristically bright and condensed nuclei. Nuclear shapes in the rhActA + OGD 6 h group were found to be less regular, with some bright and condensed nuclei as well (x400).
in the OGD 6 h group in which the endonuclear chromatin was unevenly distributed showing typical bright, condensed and densely stained forms. Fewer apoptotic cells were visible in the rhActA + OGD 6 h group compared with those in the OGD 6 h group. The apoptotic rate in the OGD 6 h group was significantly higher than that in the control group (Fig. 9) . After 24 h of rhActA stimulation, PC12 cells exhibited less cell damage compared with that observed in the untreated cells. Furthermore, consistent with the MTT results above, the apoptotic rate appeared to depend on the rhActA concentration. The apoptotic rate in the rhActA (100 ng/ml) group was slightly lower than that observed in the 50 ng/ml group, although this difference was not significant.
Effect of exogenous ActA on regulating caspase-3 protein expression in PC12 cells following OGD. On the basis of the above results, the rhActA (100 ng/ml) + OGD 6 h group was used for subsequent experiments. Results showed that the expression of pro-caspase-3 and active caspase-3 after 6 h of OGD alone was higher than that of the control group not experiencing deprivation (P<0.05) (Figs. 10 and 11) . Furthermore, caspase-3 expression after 6 h of OGD alone showed a marked increase compared with that in cells co-stimulated with rhActA (P<0.05).
Effect of exogenous ActA on ActRIIA, Smad3 and Smad4 protein expression after PC12 cells were subjected to OGD. Protein expression of ActRIIA, Smad3 and Smad4 in the OGD 6 h group was higher than that in the control group (P<0.05) (Figs. 12 and 13) . By contrast, pretreatment with rhActA significantly decreased the expression of ActRIIA after 6 h of OGD (P<0.05) compared with the OGD 6 h group. The expression of caspase-3 after stimulation with rhActA. After stimulating PC12 cells with 100 ng/ml rhActA, they were subjected to oxygen/glucose deprivation (OGD). After an additional 6 h, the expression of pro-caspase-3 and active caspase-3 was detected using western blotting. The expression of these proteins in the rhActA + OGD 6 h group was lower than that in the OGD alone group. Figure 11 . Cleaved-caspase-3 protein expression. After pretreatment of PC12 cells with rhActA, the cells were subjected to oxygen/glucose deprivation (OGD). Cleaved-caspase-3 protein in the pretreated group was lower than that of the OGD group alone. Data are presented as the mean ± SD (n=9, * P<0.05 vs. control; △ P<0.05 vs. OGD 6 h group). Figure 12 . Effects of rhActA pretreatment on the expression of ActRIIA, Smad3 and Smad4 after oxygen/glucose deprivation (OGD). After pretreatment with 100 ng/ml rhActA, PC12 cells were subjected to OGD. The expression of ActRIIA, Smad3 and Smad4 proteins was detected using western blotting. The expression of these proteins in rhActA + OGD 6 h group was higher than that in the OGD group. 
Discussion
Results of the present study have shown that ActA is a fundamental regulator of histiocytes, participating in histiocyte growth, as well as aiding in the maintenance of their normal function. The biological activity of ActA is restricted to target cell types, suggesting its tissue specificity. As a neuronal growth factor, ActA has a protective role against many factors, inducing nerve injuries. It has been found that ActA plays an active role in neuronal repair after brain injury (2) . Shoji and colleagues (11) have found that activins can increase the synapse number and dendritic crest neck length of seahorse neurons cultured in vitro. Other brain injuries, such as those caused by acute anoxia/ischemia, also cause ActA to increase in expression. Therefore, ActA has been described as an early transient ischemic and anoxic regulatory gene (12) . It is confirmed that calcitonin gene-related peptide (CGRP) has a nerve-protective function and is capable of regulating axonal regeneration (13) . ActA has been shown to stimulate the expression of DRG in vitro (14) , and DRG and CGRP in vivo (15) . An increasing number of studies suggest that recombinant activins likely alleviate post-ischemic nerve injury. This mechanism may occur because an activin induces basic fibroblast growth factor (bFGF) expression, and dopaminergic neuron generation. Thus, there may be a synergistic protective effect between recombinant activin and bFGF (2, 16) . Of note, previous studies (17) have also revealed that activins regulate apoptosis. For example, ActA has been found to prevent apoptosis in hepatocytes. As a regulatory factor of hepatocyte proliferation, it is able to induce DNA synthesis by affecting mitogens and regulate hepatocyte growth. This effect has been shown to be mediated by activin type I and type II receptors on the cell surface (17, 18) . The dose-dependent inhibition of ActA on apoptosis confirms the role of ActA in promoting cell survival.
Caspases are cysteine-aspartic proteases that share amino acid similarity and secondary structure cysteine proteases. These proteins are closely associated with ukaryotic apoptosis. Caspase-3 activation is a pivotal point of a number of apoptotic pathways. Furthermore, caspase-3 may be an important effector in ischemic neuronal apoptosis (19) and directly leads to cell death (20) . Administration of a caspase-3 inhibitor after 9 h of mouse cerebral ischemia has been shown to effectively reduce cerebral infarction size (21) . Furthermore, after 2 h of unilateral middle cerebral artery occlusion in mice, the occurrence of cerebral post-ischemic neuronal apoptosis has been shown to be closely associated with caspase-3 activity, as well as increasing split products. Following ischemic reperfusion, caspase-3 protein expression has also been shown to increase to different extents (22, 23) .
In the present study, we established a novel neuronal-like OGD model that can be used to study the effects of anoxia and ischemia in vitro. This was accomplished by inducing the differentiation of PC12 cells with NGF prior to oxygen and glucose deprivation. Using this novel OGD model, we have demonstrated that there was an increased amount of apoptosis over time, indicating that the OGD model was successful.
We also demonstrated that ActA pretreatment prevented apoptosis and promoted cell viability after OGD. Caspase-3 protein expression in cells was increased after OGD, which was partially abrogated by ActA pretreatment. Additionally, we found that ActA pretreatment increased the expression of ActRIIA, Smad3 and Smad4, even after OGD. This finding suggests that activation of the ActA/Smad signal transduction pathway might prevent neuronal injury due to ischemia and anoxia. The ActA/Smads pathway activation induced by transient ischemic injury in the course of cerebral ischemia may therefore also play a protective role. It is likely through the ActA/Smad signal transduction that ActA protects against cell apoptosis and protects neurons.
In conclusion, our study results suggest that ActA potentially plays a protective role in ischemic and anoxic neuronal injury through the ActA/Smad signal transduction pathway. This protective effect may be mediated in part by downregulating caspase-3 expression. However, how the activation of the ActA/Smad signal transduction pathway inhibits apoptotic processes and caspase-3 expression remains to be determined. Additional studies are required to elucidate the underlying mechanism of action of the protective effects of ActA.
